Healthways (HWAY) Reports Third-Quarter Earnings of $0.26 Per Diluted Share
Oct. 22, 2009 (Business Wire) — Healthways, Inc. (NASDAQ: HWAY) today announced financial results for the third quarter and nine months ended September 30, 2009. Total revenues for the quarter were $181.6 million compared with revenues of $187.4 million for the three months ended September 30, 2008. Net income for the third quarter of 2009 was $8.8 million, or $0.26 per diluted share, which was two cents above the Company’s earnings guidance range. Net income for the third quarter of 2008 was $15.6 million, or $0.45 per diluted share.
COMPARISON OF COMPONENTS OF NET INCOME PER DILUTED SHARE | ||||||||||||
Three Months Ended September 30, | ||||||||||||
2009 | 2009 | 2008 | ||||||||||
Actual | Guidance | Actual | ||||||||||
Domestic | $ | 0.29 | $ | 0.22 – 0.25 | $ | 0.47 | ||||||
International | (0.03 | ) | (0.02)-(0.01 | ) | (0.02 | ) | ||||||
Net income per diluted share | $ | 0.26 | $ | 0.20 – 0.24 | $ | 0.45 | ||||||
Ben R. Leedle, Jr., chief executive officer of Healthways, commented, “The performance of our domestic operations once again enabled us to exceed our revenue and earnings expectations for the quarter. These better than expected results for the third quarter were driven primarily by the timing of performance-based revenue recognition, as certain performance targets were measured and achieved earlier than forecast, and by higher than projected billed lives. The strong earnings performance by our domestic operations was slightly offset by higher than anticipated net costs in our international operations, primarily related to the start-up of the Australian contract with Hospitals Contribution Fund.
“The Company’s cash flow from operations was a strong $42.1 million for the third quarter. In addition to investing approximately $13.4 million in capital expenditures during the quarter, we also reduced our debt by $34.1 million. This reduction contributed to a debt to EBITDA ratio as calculated under our credit agreement of 2.0 at the end of the quarter, which is the low end of the forecasted range for 2009. Combined with our debt reduction during the first six months of the year, our total debt to capitalization has improved 410 basis points to 42.1% at the end of the third quarter from 46.2% at December 31, 2008.
“Since the beginning of the third quarter, we have signed new, expanded or extended contracts that reflect demand across the breadth of our solutions from new and existing Healthways customers, representing regional Blue Cross Blue Shield health plans, state governments, and Fortune 100 employers. Under these agreements, we will provide our chronic condition management, Silver Sneakers®, QuitNet® comprehensive smoking cessation, lifestyle health coaching, and/or WholeHealth solutions.
“Among these customers, we are pleased to report today a significant new agreement that expands our long-term relationship with Health Care Service Corporation (HCSC), one of the nation’s largest health plans. Under the terms of this multi-year agreement, Healthways will make its national fitness center network available to approximately 6.7 million of HCSC’s commercial members. With this unique business model and related services, we have created a new consumer solution designed to support healthy behaviors for individuals in a commercial population. This agreement is a further example of how our extensive infrastructure allows for the rapid creation of innovative solutions that differentiate Healthways competitively in the commercial market, just as Silver Sneakers has done in the Medicare Advantage market.”
Financial Guidance
Based on the performance of the Company’s domestic operations for the first nine months of 2009, Healthways today increased its guidance for 2009 revenues to a range of $708 million to $717 million from the previous range of $685 million to $700 million. This revision includes a new range for revenues from domestic operations of $691 million to $697 million, up from $668 million to $680 million previously. Guidance for 2009 revenues from international operations remains unchanged in a range of $17 million to $20 million.
COMPARISON OF COMPONENTS OF REVENUES FOR THE YEAR ENDING
DECEMBER 31, 2009 (GUIDANCE) AND THE YEAR ENDED DECEMBER 31, 2008 |
||||||
(Dollars in millions) | ||||||
Twelve Months | ||||||
Ending | Ended | |||||
Dec. 31, 2009 | Dec. 31, 2008 | |||||
(Guidance) | (Actual) | |||||
Domestic | $ | 691.0 – 697.0 | $ | 731.3 | ||
International | 17.0 – 20.0 | 15.4 | ||||
Total Company | $ | 708.0 – 717.0 | $ | 746.7 | ||
Due to the anticipated increase in 2009 revenues, Healthways also revised its guidance for 2009 adjusted net income per diluted share, which excludes previously announced lawsuit settlement costs of $0.73 per diluted share, to a range of $1.01 to $1.05 compared with the previous range of $0.97 to $1.05. This new earnings guidance also reflects the expected $0.02 per diluted share net cost impact of the HealthHonors acquisition announced last week. Guidance for 2009 adjusted net income per diluted share includes a new range for domestic operations of $1.13 to $1.15 compared with $1.07 to $1.13 previously, while the net cost impact from international operations has increased to a range of $0.10 to $0.12 from the previous range of $0.08 to $0.10.
The Company’s guidance for net income per diluted share for the fourth quarter of 2009 is in a range of $0.19 to $0.23. Domestic operations are expected to produce net income per diluted share of $0.20 to $0.22, including the effect of the HealthHonors acquisition. Fourth-quarter 2009 results from international operations are expected to be in a range of $0.01 net cost per diluted share to $0.01 net income per diluted share.
COMPARISON OF COMPONENTS OF NET INCOME PER DILUTED SHARE | ||||||||||||
See page 8 for a reconciliation of GAAP and non-GAAP results | ||||||||||||
Twelve Months | Three Months | |||||||||||
Ending | Ended | Ending | ||||||||||
Dec. 31, 2009 | Dec. 31, 2008 | Dec. 31, 2009 | ||||||||||
(Guidance) | (Actual) | (Guidance) | ||||||||||
Domestic, excluding lawsuit settlement costs | $ | 1.13 – 1.15 | $ | 1.20 | $ | 0.20 – 0.22 | ||||||
International | (0.12)-(0.10 | ) | (0.10 | ) | (0.01)- 0.01 | |||||||
Adjusted net income per diluted share | 1.01 – 1.05 | 1.10 | 0.19 – 0.23 | |||||||||
Lawsuit settlement costs | (0.73 | ) | – | – | ||||||||
Net income per diluted share | $ | 0.28 – 0.32 | $ | 1.10 | $ | 0.19 – 0.23 | ||||||
Summary
Mr. Leedle concluded, “We are pleased by the better than expected financial performance of our domestic operations for the third quarter and throughout 2009 and by our continued contracting momentum. We are also building our potential for future growth through the expansion of our value proposition as evidenced by our recently announced third-quarter WholeHealth contract with a Fortune 100 company and our new contract with HCSC.
“While encouraged by the Company’s progress, we remain cautious in our near-term outlook because of uncertainty about the economic environment and the possible impact of both the high domestic unemployment rate and potential healthcare reform on our customers. Given today’s economic environment, we believe the timeframe for sustained and significant improvement in the rate of unemployment is still unclear and that the possibility remains for further attrition. Despite our caution, we believe we are well positioned to continue managing through the current environment, with substantial cash flow from operations, a strengthening financial position and ample liquidity.
“Longer-term, we remain confident of the Company’s prospects for further substantial growth. In both the U.S and internationally, health plans, employers and governments are increasingly focused on the potential for reducing the future growth of healthcare costs by reducing health risks and preventing or delaying disease onset and progression. Healthways has been a leading pioneer in the development and application of these strategies with a proven record that healthier people cost less. With solutions demonstrated to be the most comprehensive, integrated and scalable in the market, we are well positioned to leverage this increased focus to expand the populations we serve and, through successful performance, to create further shareholder value.”
Conference Call
Healthways will hold a conference call to discuss this release today at 5:00 p.m. Eastern Time. Investors will have the opportunity to listen to the conference call live over the Internet by going to www.healthways.com and clicking Investor Relations, or by going to www.earnings.com, at least 15 minutes early to register, download and install any necessary audio software. For those who cannot listen to the live broadcast, a telephonic replay will be available for one week at 719-457-0820, code 5006460, and the replay will also be available on the Company’s web site for the next 12 months.
Safe Harbor Provisions
This press release contains forward-looking statements, including our guidance and financial expectations for future periods, which are based upon current expectations and involve a number of risks and uncertainties. Those forward-looking statements include all statements that are not historical statements of fact and those regarding the intent, belief or expectations of the Company, including, without limitation, all statements regarding the Company’s future earnings and results of operations. In order for the Company to utilize the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995, investors are hereby cautioned that the following important factors, among others, may affect these forward-looking statements. Consequently, actual operations and results may differ materially from those expressed in these forward-looking statements. The important factors include but are not limited to:
- the Company’s ability to sign and implement new contracts;
- the Company’s ability to accurately forecast performance in order to provide forward-looking guidance;
- the Company’s ability to reach mutual agreement with the Centers for Medicare and Medicaid Services (CMS) with respect to the Company’s results under Phase I of Medicare Health Support;
- the Company’s ability to accurately forecast the costs necessary to establish a presence in international markets;
- the risks associated with foreign currency exchange rate fluctuations;
- the Company’s ability to achieve estimated annualized revenue in backlog;
- the ability of the Company’s customers to provide timely and accurate data that is essential to the operation and measurement of the Company’s performance;
- the risks associated with changes in macroeconomic conditions;
- the Company’s ability to integrate acquired businesses or technologies into the Company’s business;
- the Company’s ability to renew and/or maintain contracts with its customers under existing terms or restructure these contracts on terms that would not have a material negative impact on the Company’s results of operations;
- the Company’s ability to obtain adequate financing to provide the capital that may be necessary to support the Company’s operations and to support or guarantee the Company’s performance under new contracts;
- the impact of litigation involving the Company and/or its subsidiaries;
- the impact of future state, federal, and international health care and other applicable legislation and regulations, including health care reform, on the Company’s ability to deliver its services and on the financial health of the Company’s customers and their willingness to purchase the Company’s services; and
- other risks detailed in the Company’s Annual Report on Form 10-K for the fiscal year ended August 31, 2008, Item 1A of the Company’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2009, and other filings with the Securities and Exchange Commission.
The Company undertakes no obligation to update or revise any such forward-looking statements.
About Healthways
Healthways is the leading provider of specialized, comprehensive solutions to help millions of people maintain or improve their health and well-being and, as a result, reduce overall costs. Healthways’ solutions are designed to help healthy individuals stay healthy, mitigate and slow the progression of disease associated with family or lifestyle risk factors and promote the best possible health for those already affected by disease. Our proven, evidence-based programs provide highly specific and personalized interventions for each individual in a population, irrespective of age or health status, and are delivered to consumers by phone, mail, internet and face-to-face interactions, both domestically and internationally. Healthways also provides a national, fully accredited complementary and alternative Health Provider Network and a national Fitness Center Network, offering convenient access to individuals who seek health services outside of, and in conjunction with, the traditional healthcare system. For more information, please visit www.healthways.com.
HEALTHWAYS, INC. | |||||||||||||
CONSOLIDATED STATEMENTS OF OPERATIONS | |||||||||||||
(Unaudited) | |||||||||||||
(In thousands, except per share data) | |||||||||||||
Three Months Ended | Nine Months Ended | ||||||||||||
September 30, | September 30, | ||||||||||||
2009 | 2008 | 2009 | 2008 | ||||||||||
Revenues | $ | 181,642 | $ | 187,448 | $ | 542,214 | $ | 561,432 | |||||
Cost of services (exclusive of depreciation and amortization of $8,517, $9,316, $25,843, and $27,116, respectively, included below) | 132,498 | 125,628 | 393,097 | 381,884 | |||||||||
Selling, general & administrative expenses | 17,816 | 17,493 | 55,050 | 55,156 | |||||||||
Depreciation and amortization | 11,956 | 12,949 | 36,155 | 37,813 | |||||||||
Operating income | 19,372 | 31,378 | 57,912 | 86,579 | |||||||||
Gain on sale of investment | — | — | (2,581 | ) | — | ||||||||
Interest expense | 3,888 | 5,366 | 12,091 | 15,529 | |||||||||
Legal settlement and related costs | — | — | 39,956 | — | |||||||||
Income before income taxes | 15,484 | 26,012 | 8,446 | 71,050 | |||||||||
Income tax expense | 6,682 | 10,389 | 5,582 | 28,900 | |||||||||
Net income | $ | 8,802 | $ | 15,623 | $ | 2,864 | $ | 42,150 | |||||
Earnings per share: | |||||||||||||
Basic | $ | 0.26 | $ | 0.46 | $ | 0.08 | $ | 1.22 | |||||
Diluted | $ | 0.26 | $ | 0.45 | $ | 0.08 | $ | 1.17 | |||||
Weighted average common shares and equivalents: | |||||||||||||
Basic | 33,745 | 33,599 | 33,701 | 34,474 | |||||||||
Diluted | 34,481 | 34,567 | 34,232 | 35,891 | |||||||||
Healthways, Inc. | ||||
Statistical Information | ||||
(Unaudited) | ||||
September 30, | September 30, | |||
2009 | 2008 | |||
Operating Statistics | ||||
Domestic commercial available lives | 196,100,000 | 192,500,000 | ||
Domestic commercial billed lives | 35,900,000 | 31,700,000 | ||
Healthways, Inc. | |||||
Reconciliation of Non-GAAP Measures to GAAP Measures | |||||
(Unaudited) | |||||
Reconciliation of Domestic EPS Guidance Excluding Lawsuit Settlement Costs and
Reconciliation of Adjusted EPS Guidance to EPS Guidance, GAAP Basis |
|||||
Twelve Months Ending | |||||
December 31, 2009 | |||||
Domestic EPS guidance excluding lawsuit settlement costs (1) | $ | 1.13 – 1.15 | |||
International EPS (loss) guidance | (0.12) – (0.10 | ) | |||
Adjusted EPS guidance (2) | $ | 1.01– 1.05 | |||
EPS (loss) attributable to lawsuit settlement costs (3) | (0.73 | ) | |||
EPS guidance, GAAP basis | $ | 0.28 – 0.32 | |||
(1) Domestic EPS guidance excluding lawsuit settlement costs is a non-GAAP financial measure. The Company excludes EPS (loss) attributable to lawsuit settlement costs from this measure because of its comparability to the Company’s historical operating results. The Company believes it is useful to investors to provide disclosures of its operating results and guidance on the same basis as that used by management. You should not consider Domestic EPS guidance excluding lawsuit settlement costs in isolation or as a substitute for EPS guidance determined in accordance with accounting principles generally accepted in the United States.
(2) Adjusted EPS guidance is a non-GAAP financial measure. The Company excludes EPS (loss) attributable to lawsuit settlement costs from this measure because of its comparability to the Company’s historical operating results. The Company believes it is useful to investors to provide disclosures of its operating results and guidance on the same basis as that used by management. You should not consider Adjusted EPS guidance in isolation or as a substitute for EPS guidance determined in accordance with accounting principles generally accepted in the United States.
(3) EPS (loss) attributable to lawsuit settlement costs consists of pre-tax charges of $40.0 million related to the Company’s settlement of a qui tam lawsuit.
HEALTHWAYS, INC. | |||||||||
CONSOLIDATED BALANCE SHEETS | |||||||||
(Unaudited) | |||||||||
(In thousands) | |||||||||
ASSETS | |||||||||
September 30, | December 31, | ||||||||
2009 | 2008 | ||||||||
Current assets: | |||||||||
Cash and cash equivalents | $ | 2,309 | $ | 5,157 | |||||
Accounts receivable, net | 121,924 | 115,108 | |||||||
Prepaid expenses | 11,325 | 13,479 | |||||||
Other current assets | 5,618 | 3,810 | |||||||
Income taxes receivable | 8,415 | — | |||||||
Deferred tax asset | 26,404 | 30,488 | |||||||
Total current assets | 175,995 | 168,042 | |||||||
Property and equipment: | |||||||||
Leasehold improvements | 41,270 | 34,635 | |||||||
Computer equipment and related software | 148,212 | 138,369 | |||||||
Furniture and office equipment | 29,006 | 29,610 | |||||||
Capital projects in process | 32,577 | 17,462 | |||||||
251,065 | 220,076 | ||||||||
Less accumulated depreciation | (132,841 | ) | (108,635 | ) | |||||
118,224 | 111,441 | ||||||||
Other assets | 7,063 | 18,089 | |||||||
Customer contracts, net | 28,652 | 32,715 | |||||||
Other intangible assets, net | 66,563 | 68,207 | |||||||
Goodwill, net | 484,584 | 484,596 | |||||||
Total assets | $ | 881,081 | $ | 883,090 | |||||
HEALTHWAYS, INC. | ||||||||
CONSOLIDATED BALANCE SHEETS | ||||||||
(In thousands, except share and per share data) | ||||||||
(Unaudited) | ||||||||
LIABILITIES AND STOCKHOLDERS’ EQUITY | ||||||||
September 30, | December 31, | |||||||
2009 | 2008 | |||||||
Current liabilities: | ||||||||
Accounts payable | $ | 22,399 | $ | 21,633 | ||||
Accrued salaries and benefits | 65,168 | 33,161 | ||||||
Accrued liabilities | 26,873 | 26,294 | ||||||
Deferred revenue | 5,060 | 6,904 | ||||||
Contract billings in excess of earned revenue | 75,099 | 71,406 | ||||||
Income taxes payable | — | 8,034 | ||||||
Current portion of long-term debt | 2,657 | 2,035 | ||||||
Current portion of long-term liabilities | 4,371 | 4,609 | ||||||
Total current liabilities | 201,627 | 174,076 | ||||||
Long-term debt | 263,852 | 304,372 | ||||||
Long-term deferred tax liability | 10,898 | 8,073 | ||||||
Other long-term liabilities | 38,181 | 39,533 | ||||||
Stockholders’ equity: | ||||||||
Preferred stock | ||||||||
$.001 par value, 5,000,000 shares authorized, none outstanding | — | — | ||||||
Common stock | ||||||||
$.001 par value, 120,000,000 shares authorized, 33,790,729 and 33,648,976 shares outstanding | 34 | 34 | ||||||
Additional paid-in capital | 220,060 | 213,461 | ||||||
Retained earnings | 151,370 | 148,506 | ||||||
Accumulated other comprehensive loss | (4,941 | ) | (4,965 | ) | ||||
Total stockholders’ equity | 366,523 | 357,036 | ||||||
Total liabilities and stockholders’ equity | $ | 881,081 | $ | 883,090 | ||||
HEALTHWAYS, INC. | ||||||||
CONSOLIDATED STATEMENTS OF CASH FLOWS | ||||||||
(Unaudited) | ||||||||
(In thousands) | ||||||||
Nine Months EndedSeptember 30, | ||||||||
2009 | 2008 | |||||||
Cash flows from operating activities: | ||||||||
Net income | $ | 2,864 | $ | 42,150 | ||||
Adjustments to reconcile net income to net cash provided by operating activities, net of business acquisitions: | ||||||||
Depreciation and amortization | 36,155 | 37,813 | ||||||
Amortization of deferred loan costs | 1,128 | 881 | ||||||
Gain on sale of investment | (2,581 | ) | — | |||||
Loss on disposal of property and equipment | 955 | 1,346 | ||||||
Share-based employee compensation expense | 7,863 | 12,714 | ||||||
Excess tax benefits from share-based payment arrangements | (162 | ) | (3,487 | ) | ||||
Increase in accounts receivable, net | (6,776 | ) | (19,049 | ) | ||||
(Increase) decrease in other current assets | (5,490 | ) | 1,926 | |||||
Increase in accounts payable | 4,462 | 2,968 | ||||||
Increase in accrued salaries and benefits | 31,965 | 15,640 | ||||||
(Decrease) increase in other current liabilities | (3,667 | ) | 2,341 | |||||
Deferred income taxes | 5,339 | (7,727 | ) | |||||
Other | 3,479 | 8,002 | ||||||
Increase in other assets | (454 | ) | (1,581 | ) | ||||
Payments on other long-term liabilities | (2,935 | ) | (2,156 | ) | ||||
Net cash flows provided by operating activities | 72,145 | 91,781 | ||||||
Cash flows from investing activities: | ||||||||
Acquisition of property and equipment | (35,638 | ) | (62,026 | ) | ||||
Sale of investment | 11,626 | — | ||||||
Change in restricted cash | (538 | ) | — | |||||
Other | (3,655 | ) | (4,543 | ) | ||||
Net cash flows used in investing activities | (28,205 | ) | (66,569 | ) | ||||
Cash flows from financing activities: | ||||||||
Proceeds from issuance of long-term debt | 283,900 | 87,287 | ||||||
Payments of long-term debt | (325,826 | ) | (42,965 | ) | ||||
Deferred loan costs | (784 | ) | — | |||||
Exercise of stock options | 265 | 3,668 | ||||||
Excess tax benefits from share-based payment arrangements | 162 | 3,487 | ||||||
Repurchases of common stock | — | (94,208 | ) | |||||
Repurchase of stock options | (736 | ) | — | |||||
Change in outstanding checks and other | (3,982 | ) | — | |||||
Net cash flows used in financing activities | (47,001 | ) | (42,731 | ) | ||||
Effect of exchange rate changes on cash | 213 | (76 | ) | |||||
Net decrease in cash and cash equivalents | (2,848 | ) | (17,595 | ) | ||||
Cash and cash equivalents, beginning of period | 5,157 | 40,515 | ||||||
Cash and cash equivalents, end of period | $ | 2,309 | $ | 22,920 |
TraderPower Featured Companies
Top Small Cap Market News
- $SOBR InvestorNewsBreaks – SOBR Safe Inc. (NASDAQ: SOBR) Closes on $8.2M Private Placement
- $CLNN InvestorNewsBreaks – Clene Inc. (NASDAQ: CLNN) Announces Participation at Two Upcoming Investor Conferences
- $ATBHF Aston Bay Holdings Ltd. (TSX.V: BAY) (OTCQB: ATBHF) Releases Updated Report on Storm Copper Project Drilling Program
- $LGVN InvestorNewsBreaks – Longeveron Inc. (NASDAQ: LGVN) to Present at This Month’s Congenital Heart Surgeons’ Society Annual Meeting
- $LEXX InvestorNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Begins Subject Dosing in Human Pilot Study #3 Evaluating Oral DehydraTECH-Processed Tirzepatide
- $FSTTF InvestorNewsBreaks – First Tellurium Corp. (CSE: FTEL) (OTC: FSTTF) Shares Additional Information on the PyroDelta Thermoelectric Generator, Relationship with Subsidiary
- $TMET.V Gold Stutters as Strong US Jobs Data Dampens Expectations of Large Rate Cuts
- $RFLXF JPMorgan Executive Says US Backlash Against ESG Is Exaggerated
- $SFWJ InvestorNewsBreaks – Software Effective Solutions Corp. (d/b/a MedCana) (SFWJ) Releases Report on Series of Acquisitions, Multiple Cannabis Licenses
- $EAWD IEA Hosts G20 Ministers, Influential Personalities to Discuss Clean and Affordable Energy Transition
Recent Posts
- $EAWD IEA Hosts G20 Ministers, Influential Personalities to Discuss Clean and Affordable Energy Transition
- $SFWJ InvestorNewsBreaks – Software Effective Solutions Corp. (d/b/a MedCana) (SFWJ) Releases Report on Series of Acquisitions, Multiple Cannabis Licenses
- $RFLXF JPMorgan Executive Says US Backlash Against ESG Is Exaggerated
- $TMET.V Gold Stutters as Strong US Jobs Data Dampens Expectations of Large Rate Cuts
- $FSTTF InvestorNewsBreaks – First Tellurium Corp. (CSE: FTEL) (OTC: FSTTF) Shares Additional Information on the PyroDelta Thermoelectric Generator, Relationship with Subsidiary
- $LEXX InvestorNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Begins Subject Dosing in Human Pilot Study #3 Evaluating Oral DehydraTECH-Processed Tirzepatide
- $LGVN InvestorNewsBreaks – Longeveron Inc. (NASDAQ: LGVN) to Present at This Month’s Congenital Heart Surgeons’ Society Annual Meeting
- $ATBHF Aston Bay Holdings Ltd. (TSX.V: BAY) (OTCQB: ATBHF) Releases Updated Report on Storm Copper Project Drilling Program
Recent Comments
Archives
- October 2024
- January 2023
- June 2022
- December 2021
- September 2021
- August 2021
- July 2021
- June 2021
- May 2021
- April 2021
- March 2021
- February 2021
- January 2021
- December 2020
- November 2020
- October 2020
- September 2020
- August 2020
- July 2020
- June 2020
- May 2020
- April 2020
- March 2020
- February 2020
- January 2020
- December 2019
- November 2019
- October 2019
- September 2019
- August 2019
- July 2019
- June 2019
- May 2019
- April 2019
- March 2019
- February 2019
- January 2019
- December 2018
- November 2018
- October 2018
- September 2018
- August 2018
- July 2018
- June 2018
- May 2018
- April 2018
- March 2018
- February 2018
- January 2018
- December 2017
- November 2017
- October 2017
- September 2017
- August 2017
- July 2017
- June 2017
- May 2017
- April 2017
- March 2017
- February 2017
- January 2017
- December 2016
- November 2016
- October 2016
- September 2016
- August 2016
- July 2016
- June 2016
- May 2016
- April 2016
- March 2016
- February 2016
- January 2016
- December 2015
- November 2015
- October 2015
- September 2015
- August 2015
- July 2015
- June 2015
- May 2015
- April 2015
- March 2015
- February 2015
- January 2015
- December 2014
- November 2014
- October 2014
- September 2014
- August 2014
- July 2014
- June 2014
- May 2014
- April 2014
- March 2014
- February 2014
- January 2014
- December 2013
- November 2013
- October 2013
- September 2013
- August 2013
- July 2013
- June 2013
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- September 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
- October 2010
- September 2010
- August 2010
- July 2010
- June 2010
- May 2010
- April 2010
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- September 2009
- August 2009
- July 2009
- June 2009